Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00602953 · ClinicalTrials.gov registry record
Role of Pancreatic Triglyceride Content in Beta-cell Function
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 101
- Enrollment target
NCT00602953 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 101 participants.
The verdict
NCT00602953 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 101 participants
- Enrollment target
Study Summary
The study evaluates if fat accumulates in the pancreas in individuals at risk of developing obesity-related diabetes. It also evaluates if the amount of fat in the pancreas can predict the residual functional capacity of the pancreas (insulin secretion).
Interventions
- OTHER No intervention planned.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2007-09 |
| Est. Completion | 2012-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00602953
The ClinicalTrials.gov registry entry for NCT00602953 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention planned. is the first listed.
NCT00602953 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00602953 about?
NCT00602953 is a clinical study titled "Role of Pancreatic Triglyceride Content in Beta-cell Function". The study evaluates if fat accumulates in the pancreas in individuals at risk of developing obesity-related diabetes. It also evaluates if the amount of fat in the pancreas can predict the residual functional capacity of the pancreas (insulin secretion).
What is the current status of trial NCT00602953?
This trial is currently completed. The enrollment target is 101 participants. The study started on 2007-09. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00602953?
The interventions under investigation include: No intervention planned. (OTHER).
Who is sponsoring clinical trial NCT00602953?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.